These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 33216002

  • 1. Patients' Experiences of Telephone-Based and Web-Based Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Longitudinal Qualitative Study.
    Hughes S, Sibelli A, Everitt HA, Moss-Morris R, Chalder T, Harvey JM, Vas Falcao A, Landau S, O'Reilly G, Windgassen S, Holland R, Little P, McCrone P, Goldsmith K, Coleman N, Logan R, Bishop FL.
    J Med Internet Res; 2020 Nov 20; 22(11):e18691. PubMed ID: 33216002
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Assessing telephone-delivered cognitive-behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial.
    Everitt HA, Landau S, O'Reilly G, Sibelli A, Hughes S, Windgassen S, Holland R, Little P, McCrone P, Bishop F, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R, ACTIB trial group.
    Gut; 2019 Sep 20; 68(9):1613-1623. PubMed ID: 30971419
    [Abstract] [Full Text] [Related]

  • 4. Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial.
    Everitt HA, Landau S, O'Reilly G, Sibelli A, Hughes S, Windgassen S, Holland R, Little P, McCrone P, Bishop FL, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R.
    Lancet Gastroenterol Hepatol; 2019 Nov 20; 4(11):863-872. PubMed ID: 31492643
    [Abstract] [Full Text] [Related]

  • 5. Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised controlled trial of clinical-effectiveness and cost-effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome in adults.
    Everitt H, Landau S, Little P, Bishop FL, McCrone P, O'Reilly G, Coleman N, Logan R, Chalder T, Moss-Morris R, ACTIB trial team.
    BMJ Open; 2015 Jul 15; 5(7):e008622. PubMed ID: 26179651
    [Abstract] [Full Text] [Related]

  • 6. Exploring patients' views of a cognitive behavioral therapy-based website for the self-management of irritable bowel syndrome symptoms.
    Tonkin-Crine S, Bishop FL, Ellis M, Moss-Morris R, Everitt H.
    J Med Internet Res; 2013 Sep 03; 15(9):e190. PubMed ID: 24001787
    [Abstract] [Full Text] [Related]

  • 7. The role of high expectations of self and social desirability in emotional processing in individuals with irritable bowel syndrome: A qualitative study.
    Sibelli A, Chalder T, Everitt H, Workman P, Bishop FL, Moss-Morris R.
    Br J Health Psychol; 2017 Nov 03; 22(4):737-762. PubMed ID: 28862389
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A pilot feasibility study of an unguided, internet-delivered cognitive behavioral therapy program for irritable bowel syndrome.
    Owusu JT, Sibelli A, Moss-Morris R, van Tilburg MAL, Levy RL, Oser M.
    Neurogastroenterol Motil; 2021 Nov 03; 33(11):e14108. PubMed ID: 33745228
    [Abstract] [Full Text] [Related]

  • 10. Cognitive behavioral therapy for irritable bowel syndrome: the effects on state and trait anxiety and the autonomic nervous system during induced rectal distensions - An uncontrolled trial.
    Edebol-Carlman H, Schrooten M, Ljótsson B, Boersma K, Linton S, Brummer RJ.
    Scand J Pain; 2018 Jan 26; 18(1):81-91. PubMed ID: 29794287
    [Abstract] [Full Text] [Related]

  • 11. Patients' perspectives on GP interactions after cognitive behavioural therapy for refractory IBS: a qualitative study in UK primary and secondary care.
    Sibelli A, Moss-Morris R, Chalder T, Bishop FL, Windgassen S, Everitt H.
    Br J Gen Pract; 2018 Sep 26; 68(674):e654-e662. PubMed ID: 30061195
    [Abstract] [Full Text] [Related]

  • 12. Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial.
    Kennedy TM, Chalder T, McCrone P, Darnley S, Knapp M, Jones RH, Wessely S.
    Health Technol Assess; 2006 Jun 26; 10(19):iii-iv, ix-x, 1-67. PubMed ID: 16729918
    [Abstract] [Full Text] [Related]

  • 13. Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website. (MIBS trial).
    Everitt HA, Moss-Morris RE, Sibelli A, Tapp L, Coleman NS, Yardley L, Smith PW, Little PS.
    BMC Gastroenterol; 2010 Nov 18; 10():136. PubMed ID: 21087463
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of Zemedy, a Mobile Digital Therapeutic for the Self-management of Irritable Bowel Syndrome: Crossover Randomized Controlled Trial.
    Hunt M, Miguez S, Dukas B, Onwude O, White S.
    JMIR Mhealth Uhealth; 2021 May 20; 9(5):e26152. PubMed ID: 33872182
    [Abstract] [Full Text] [Related]

  • 15. The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome.
    Lackner JM, Keefer L, Jaccard J, Firth R, Brenner D, Bratten J, Dunlap LJ, Ma C, Byroads M, IBSOS Research Group.
    Contemp Clin Trials; 2012 Nov 20; 33(6):1293-310. PubMed ID: 22846389
    [Abstract] [Full Text] [Related]

  • 16. Group cognitive behavioural therapy (GCBT) versus treatment as usual (TAU) in the treatment of irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial.
    Kikuchi S, Oe Y, Sasaki Y, Ishii H, Ito Y, Horikoshi M, Sozu T, Seno H, Furukawa TA.
    BMC Gastroenterol; 2020 Feb 04; 20(1):29. PubMed ID: 32019509
    [Abstract] [Full Text] [Related]

  • 17. Desperately seeking a cure: Treatment seeking and appraisal in irritable bowel syndrome.
    Harvey JM, Sibelli A, Chalder T, Everitt H, Moss-Morris R, Bishop FL.
    Br J Health Psychol; 2018 Sep 04; 23(3):561-579. PubMed ID: 29508539
    [Abstract] [Full Text] [Related]

  • 18. Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website.
    Everitt H, Moss-Morris R, Sibelli A, Tapp L, Coleman N, Yardley L, Smith P, Little P.
    BMC Gastroenterol; 2013 Apr 21; 13():68. PubMed ID: 23602047
    [Abstract] [Full Text] [Related]

  • 19. Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.
    Lackner JM, Jaccard J, Keefer L, Brenner DM, Firth RS, Gudleski GD, Hamilton FA, Katz LA, Krasner SS, Ma CX, Radziwon CD, Sitrin MD.
    Gastroenterology; 2018 Jul 21; 155(1):47-57. PubMed ID: 29702118
    [Abstract] [Full Text] [Related]

  • 20. Factors Associated With Efficacy of Cognitive Behavior Therapy vs Education for Patients With Irritable Bowel Syndrome.
    Lackner JM, Jaccard J, IBS Outcome Study Research Group.
    Clin Gastroenterol Hepatol; 2019 Jul 21; 17(8):1500-1508.e3. PubMed ID: 30613000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.